The global esoteric testing market is projected to reach USD 36.3 billion by 2026 from USD 21.0 billion in 2021, at a CAGR of 11.6% during the forecast period. Market growth is largely driven by the rising incidence of chronic and infectious diseases, increasing use of esoteric DNA sequencing technologies in precision medicine, early diagnosis of cancer, and advancements in the personalized medicine. Emerging markets in Asian countries are expected to offer strong growth opportunities for players in the market. In contrast, inadequate reimbursements of the esoteric test may restrict market growth to a certain extent. The esoteric testing market is segmented based on type, technology, end user and region.
Infectious disease testing segment is expected to dominate the market during the forecast period and the genetic testing segment is also expected to grow at the highest CAGR during the forecast period.
Based on product, the esoteric testing market is segmented into infectious disease testing, endocrinology testing, oncology testing, genetic testing, toxicology testing, immunology testing, neurology testing, and other testing.Infectious disease testing segment accounted the largest share of the esoteric testing market.
The largest share of the segment is attributed to the increasing incidence of infectious diseases, technological innovations in molecular diagnostics, and improving healthcare infrastructure in developing nations.The genetic testing segment is expected to register the highest CAGR during the forecast period.
The fastest growth of the genetic testing segment is attributed to the advancements in the sequencing technologies such as NGS and increasing awareness.
CLIA segment to dominate the market during the forecast period. Based on technology, esoteric testing market is segmented into chemiluminescence immunoassay (CLIA), enzyme-linked immunosorbent assay (ELISA), mass spectrometry, real-time PCR, flow cytometry, DNA sequencing, and other technologies.CLIA accounted for the largest share of the esoteric testing market in 2020.
The large share of this segment can be attributed to its advantages over other testing methods, such as high-performance levels, low detection limits, higher specificity, high signal intensity, and good precision.
Independent & reference laboratories segment to dominate the market during the forecast period. Based on end user, the esoteric testing market is segmented into independent & reference laboratories and hospital-based laboratories.Independent & reference laboratories account for the largest share of the esoteric testing market.
The largest share is attributed to the high testing volumes. In addition, the ongoing automation, and digitalization of diagnostic laboratories, growing number of accredited laboratories, significant reimbursement coverage, and the competitive benefits offered by these providers are pushing the growth of the segment.
North America will dominate the market during the forecast period. Geographically, the esoteric testing market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa.In 2020, North America accounted for the largest share of the esoteric testing market.
The large share of the North American market can be attributed to the increasing per capita healthcare expenditure, presence of the leading market players, increasing use of rapid diagnostics, expanding geriatric population, and advancing precision medicine in the region.
The primary interviews conducted for this report can be categorized as follows: • By Company Type - Tier 1: 48%, Tier 2: 40%, and Tier 3: 12% • By Designation - C-level: 26%, D-level: 30%, and Others: 44% • By Region - North America: 34%, Europe: 26%, Asia Pacific: 23%, and Rest of the World: 17%
List of Companies Profiled in the Report • Labcorp (US) • Quest Diagnostics (US) • OPKO Health (US) • H.U. Group Holdings, Inc. (Japan) • Healius Limited (Australia) • Sonic Healthcare (Australia) • Mayo Foundation for Medical Education and Research (MFMER, US) • Eurofins Scientific (Luxembourg) • Stanford Clinical Pathology (US) • Foundation Medicine (US) • Kindstar Global (Beijing) Technology, Inc. (China) • ARUP Laboratories (US) • Georgia Esoteric & Molecular Laboratory, LLC (US) • Thyrocare Technologies Ltd. (India) • ACM Global Laboratories (US) • BioAgilytix Labs (US) • National Medical Services Inc. (NMS) (US) • Baylor Esoteric and Molecular Laboratory (US) • Cerba Xpert (Belgium) • HealthQuest Esoterics (US) • BUHLMANN Diagnostics Corp (BDC, US) • BP Diagnostic Centre SDN BHD (Malaysia) • Flow Health (US) • Leo Labs, Inc. (India).
Research Coverage: This report provides a detailed picture of the global esoteric testing market.It aims at estimating the size and future growth potential of the market across different segments, such as type, technology, end user and region.
The report also analyzes factors (such as drivers, restraints, opportunities and challenges) affecting market growth.It evaluates the opportunities in the market for stakeholders and provides details of the competitive landscape for market leaders.
The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total esoteric testing market. The report forecasts the revenue of the market segments with respect to four major regions.
Reasons to Buy the Report:
The report provides insights on the following pointers: • Market Penetration: Comprehensive information on esoteric testing services offered by the top 24 players in the esoteric testing market. The report analyses the esoteric testing market by type, technology, end user and region. • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various esoteric testing services across key geographic regions. • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the esoteric testing market. • Competitive Assessment: In-depth assessment of market ranking and strategies of the leading players in the esoteric testing market.
Our reports have been used by over 10K customers, including:
histopathology services market was valued at US$ 35,187.90 million by 2028 from US$ 23,890.44 million in 2021; it is expected to grow at a CAGR of 5.7% from 2021 to 2028. Factors such as rising demand for biologics and increasing prevalence of chronic diseases are driving the growth of the histopathology services market. However, limitations...
The global Micropump market is expected to reach US$ 5,172.86 million in 2028 from as estimated value of US$ 1,553.01 million in 2021. The market is likely to grow with a CAGR of 18.8% from 2021-2028. The growth of the market is due to increasing demand for micropumps in medical device industry, and improved accuracy compared to traditional...
The ablation technology market is projected to reach USD 8.1 Billion by 2026 from USD 5.2 Billion in 2021, at a CAGR of 9.3% during the forecast period. The growing elderly population has also driven the incidence of target conditions and contributed to the demand for effective treatment. However, the reuse and reprocessing of devices in developed...
344 pages •
By The Business Research Company
• Sep 2021
Anti-Asthmatics And COPD Drugs Global Market Opportunities And Strategies To 2030: COVID-19 Implications And Growth provides the strategists, marketers and senior management with the critical information they need to assess the global anti-asthmatics and COPD drugs market as it emerges from the COVID 19 shut down. Description: Where...
The global nuclear medicine market is projected to reach USD 7.5 billion by 2026 from USD 4.8billion in 2021, at a CAGR of 9.0% during the forecast period. Growth in the nuclear medicine market can primarily be attributed to factors such as the increasing incidence and prevalence of cancer and cardiac ailments and initiatives to lessen the...
The near-infrared imaging market size is expected to grow from an estimated USD 0.8 billion in 2021 to USD 1.6 billion by 2026, at a CAGR of 14.0%. The growing number of surgical procedures performed globally, advantages of NIR imaging over conventional visualization methods, and technological advancements in NIR imaging modalities. However,...
The pen needles market is expected to reach USD 2.2 Billion by 2026 from an estimated USD 1.3 Billion in 2021, at a CAGR of 11.2%. Growth in the market is largely driven by the growing prevalence of chronic diseases and the favorable reimbursement scenario in selected countries. On the other hand, the preference for alternative modes of drug...
The global amniotic products market is projected to reach USD 1.0 billion by 2026 from USD 0.7 billion in 2021, at a CAGR of 8.2% during the forecast period. The growth in this market can be attributed to the growth in the target patient population, rising incidence of burn injuries, awareness programs for wound care treatment and management,...
The global urinalysis market size is projected to reach USD 4.9billion by 2026 from USD 3.5billion in 2021, at a CAGR of 7.2% during the forecast period. Market growth is driven by factors such as increasing burden of UTIs, diabetes, and kidney & liver diseases, rising geriatric population and the subsequent increase in age- associated diseases...
The global radiation detection, monitoring, and safety market is expected to grow at a CAGR of 6.9% during the forecast period to reach USD 3.1 billion by 2026 from an estimated USD 2.2 billion in 2021. The key factors propelling the growth of this market are growing security threats, the growing prevalence of cancer worldwide, increasing...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.